Your browser doesn't support javascript.
loading
Treatment with aromatase inhibitors stimulates the expression of epidermal growth factor receptor-1 and neuregulin 1 in ER positive/HER-2/neu non-amplified primary breast cancers.
Flågeng, Marianne Hauglid; Larionov, Alexey; Geisler, Jürgen; Knappskog, Stian; Prestvik, Wenche S; Bjørkøy, Geir; Lilleng, Peer Kåre; Dixon, J Michael; Miller, William R; Lønning, Per Eystein; Mellgren, Gunnar.
Afiliación
  • Flågeng MH; Department of Clinical Science, University of Bergen, 5021 Bergen, Norway; Hormone Laboratory, Haukeland University Hospital, 5021 Bergen, Norway. Electronic address: Marianne.flageng@uib.no.
  • Larionov A; University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, United Kingdom; Department of Medical Genetics, Cambridge University, Cambridge, United Kingdom. Electronic address: alexey_larionov@hotmail.com.
  • Geisler J; Department of Oncology, Akershus University Hospital, 1478 Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, 0316 Oslo, Norway. Electronic address: juergen.geisler@medisin.uio.no.
  • Knappskog S; Department of Clinical Science, University of Bergen, 5021 Bergen, Norway; Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway. Electronic address: stian.knappskog@uib.no.
  • Prestvik WS; Department of Technology, University College of Sør-Trøndelag, 7491 Trondheim, Norway. Electronic address: wenche.s.prestvik@hist.no.
  • Bjørkøy G; Department of Technology, University College of Sør-Trøndelag, 7491 Trondheim, Norway. Electronic address: geir.bjorkoy@hist.no.
  • Lilleng PK; The Gades Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, 5021 Bergen, Norway; Department of Pathology, Haukeland University Hospital, 5021 Bergen, Norway. Electronic address: peer.kare.lilleng@helse-bergen.no.
  • Dixon JM; University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, United Kingdom. Electronic address: Mike.Dixon@ed.ac.uk.
  • Miller WR; University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, United Kingdom. Electronic address: w.r.miller@ed.ac.uk.
  • Lønning PE; Department of Clinical Science, University of Bergen, 5021 Bergen, Norway; Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway. Electronic address: Marianne.flageng@uib.no.
  • Mellgren G; Department of Clinical Science, University of Bergen, 5021 Bergen, Norway; Hormone Laboratory, Haukeland University Hospital, 5021 Bergen, Norway. Electronic address: Marianne.flageng@uib.no.
J Steroid Biochem Mol Biol ; 165(Pt B): 228-235, 2017 01.
Article en En | MEDLINE | ID: mdl-27343990
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Regulación Neoplásica de la Expresión Génica / Neurregulina-1 / Inhibidores de la Aromatasa / Receptores ErbB Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Revista: J Steroid Biochem Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Regulación Neoplásica de la Expresión Génica / Neurregulina-1 / Inhibidores de la Aromatasa / Receptores ErbB Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Revista: J Steroid Biochem Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA Año: 2017 Tipo del documento: Article